scholarly journals Multiple cutaneous infections caused by Prototheca wickerhamii

2020 ◽  
Vol 34 (11) ◽  
Author(s):  
Feng Zhao ◽  
Miaode Chen ◽  
Ying Fu
Keyword(s):  
Cutaneous Infections ◽  
Prototheca Wickerhamii

Common cutaneous infections

Medicine ◽  
2021 ◽  
Author(s):  
Roberto Corso ◽  
Rachael Morris Jones
Keyword(s):  
Cutaneous Infections

scholarly journals Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review

2021 ◽  
Vol 10 (5) ◽  
pp. 1040
Author(s):  
Jo L. W. Lambert ◽  
Sofie De Schepper ◽  
Reinhart Speeckaert
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Cutaneous Manifestations ◽  
Cutaneous Infections ◽  
Tnf Α ◽  
Common Skin ◽  
Receptor Blockers ◽  
Infusion Reactions ◽  
Inflammatory Bowel ◽  
Lichenoid Reactions

The biologic era has greatly improved the treatment of Crohn’s disease and ulcerative colitis. Biologics can however induce a wide variety of skin eruptions, especially those targeting the TNF-α and Th17 pathway. These include infusion reactions, eczema, psoriasis, lupus, alopecia areata, vitiligo, lichenoid reactions, granulomatous disorders, vasculitis, skin cancer, and cutaneous infections. It is important to recognize these conditions as treatment-induced adverse reactions and adapt the treatment strategy accordingly. Some conditions can be treated topically while others require cessation or switch of the biological therapy. TNF-α antagonists have the highest rate adverse skin eruptions followed by ustekinumab and anti-integrin receptor blockers. In this review, we provide an overview of the most common skin eruptions which can be encountered in clinical practice when treating IBD (Inflammatory bowel disease) patients and propose a therapeutic approach for each condition.

Treatment of cutaneous infections

2008 ◽  
Vol 21 (3) ◽  
pp. 153-153
Author(s):  
Jana Hercogova
Keyword(s):  
Cutaneous Infections

scholarly journals Panton-Valentine Leukocidin-Positive and Toxic Shock Syndrome Toxin 1-Positive Methicillin-ResistantStaphylococcus aureus: a French Multicenter Prospective Study in 2008

2011 ◽  
Vol 55 (4) ◽  
pp. 1734-1739 ◽  
Author(s):  
Jérôme Robert ◽  
Anne Tristan ◽  
Laurent Cavalié ◽  
Jean-Winoc Decousser ◽  
Michèle Bes ◽  
...  
Keyword(s):  
Respiratory Infections ◽  
Young Patients ◽  
Toxic Shock ◽  
Cutaneous Infections ◽  
Toxic Shock Syndrome Toxin ◽  
Multicenter Prospective Study ◽  
Mrsa Strains ◽  
Low Prevalence ◽  
Panton Valentine Leukocidin ◽  
Valentine Leukocidin

ABSTRACTThe epidemiology of community-acquired methicillin-resistantStaphylococcus aureus(CA-MRSA) differs from country to country. We assess the features of the ST80 European clone, which is the most prevalent PVL-positive CA-MRSA clone in Europe, and the TSST-1 ST5 clone that was recently described in France. In 2008, all MRSA strains susceptible to fluoroquinolones and gentamicin and resistant to fusidic acid that were isolated in 104 French laboratories were characterized usingagralleles,spatyping, and the staphylococcal cassette chromosomemecelement and PCR profiling of 21 toxin genes. Three phenotypes were defined: (i) kanamycin resistant, associated with the ST80 clone; (ii) kanamycin and tobramycin resistant, associated with the ST5 clone; and (iii) aminoglycoside susceptible, which was less frequently associated with the ST5 clone. Among the 7,253 MRSA strains isolated, 91 (1.3%) were ST80 CA-MRSA (89 phenotype 1) and 190 (2.6%) were ST5 CA-MRSA (146 phenotype 2, 42 phenotype 3). Compared to the latter, ST80 CA-MRSAs were more likely to be community acquired (80% versus 46%) and found in young patients (median age, 26.0 years versus 49.5 years) with deep cutaneous infections (48% versus 6%). They were less likely to be tetracycline susceptible (22% versus 85%) and to be isolated from respiratory infections (6% versus 27%). The TSST-1 ST5 clone has rapidly emerged in France and has become even more prevalent than the ST80 European clone, whose prevalence has remained stable. The epidemiological and clinical patterns of the two clones differ drastically. Given the low prevalence of both among all staphylococcal infections, no modification of antibiotic recommendations is required yet.

scholarly journals Sporotrichoid-Like Spread of Cutaneous Mycobacterium chelonae in an Immunocompromised Patient

2017 ◽  
Vol 2017 ◽  
pp. 1-3
Author(s):  
Daria Marley Kemp ◽  
Anusha G. Govind ◽  
Jun Kang ◽  
Caroline C. Brugger ◽  
Young C. Kauh
Keyword(s):  
Lupus Erythematosus ◽  
Soft Tissues ◽  
Immunocompromised Patient ◽  
Immunocompromised Patients ◽  
Systemic Lupus ◽  
Mycobacterium Chelonae ◽  
Cutaneous Infections ◽  
Subcutaneous Nodules ◽  
Immunosuppressive Medications ◽  
Atypical Presentations

Mycobacterium chelonae is a rapidly growing mycobacterium found in water and soil that can cause local cutaneous infections in immunocompetent hosts but more frequently affects immunocompromised patients. Typically, patients will present with painful subcutaneous nodules of the joints or soft tissues from traumatic inoculation. However, exhibiting a sporotrichoid-like pattern of these nodules is uncommon. Herein, we report a case of sporotrichoid-like distribution of cutaneous Mycobacterium chelonae in a patient with systemic lupus erythematosus on significant immunosuppressive medications. Clinicians treating immunocompromised patients should be cognizant of their propensity to develop unusual infections and atypical presentations.

scholarly journals Prototheca wickerhamii breast implant infection after reconstructive surgery: A new level of complexity

2021 ◽  
Author(s):  
Joanne S.K. Teh ◽  
Amalie E. Wilke ◽  
Simon M. Overstall ◽  
Jasmine C. Teng ◽  
Ruth Chin ◽  
...  
Keyword(s):  
Reconstructive Surgery ◽  
Breast Implant ◽  
Implant Infection ◽  
Prototheca Wickerhamii
Sign in / Sign up

Export Citation Format

Share Document